Evidence map›Paper›PMID 27726176›Full record

ArticleJournal of clinical laboratory analysis2017

Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.

Fen Ji, Shuqin Zhang, Xia Jiang, Yuyin Xu, Zhiwei Chen, Yaping Fan, Wenjuan Wang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018
    Observational
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fen JiDepartment of Nephrology, The Second People's Hospital of Nantong, Nantong, Jiangsu, China.
Shuqin ZhangDepartment of Nephrology, The Second People's Hospital of Nantong, Nantong, Jiangsu, China.
Xia JiangDepartment of Nephrology, The Second People's Hospital of Nantong, Nantong, Jiangsu, China.
Yuyin XuDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Zhiwei ChenDepartment of Nephrology, The Second People's Hospital of Nantong, Nantong, Jiangsu, China.
Yaping FanDepartment of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Wenjuan WangDepartment of Nephrology, The Second People's Hospital of Nantong, Nantong, Jiangsu, China.
Second People's Hospital of NanTong · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study was undertaken to determine the diagnostic and prognostic values of galectin-3 (Gal-3) in patients with chronic kidney disease (CKD).

methodsPatients with CKD (n=150) were enrolled as the CKD group, which was divided into six groups according to glomerular filtration rates (GFR) indexes. At the same time, 50 healthy adults were chosen for the control group (NC). Measured data included the levels of serum Gal-3, serum creatinine (SCr), β

resultsThere was no significant difference between CKD and NC group in age, gender and the level of Alb. CKD group had lower estimated glomerular filtration rate (eGFR) but higher Gal-3, CysC, SCr, β

conclusionsOur study verified Gal-3, CysC and SCr were negatively related to eGFR. Besides, it is suggested that Gal-3 can be used as an indicating factor in the diagnosis of CKD; the joint analysis of Gal-3, CysC and SCr for CKD may distinctly improve diagnostic accuracy.

Indexed as

AdultBlood ProteinsCreatinineCystatin CFemaleGalectin 3GalectinsGlomerular Filtration RateHumansMaleMiddle AgedPrognosisRenal Insufficiency, ChronicROC CurveSurvival AnalysisBlood ProteinsCreatinineCystatin CGalectin 3GalectinsLGALS3 protein, humanchronic kidney diseasediagnosisGal-3glomerular filtration ratesprognosis

Identifiers

PMID27726176
PMCPMC6816969
OpenAlexW2530501861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.